![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1808832
¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀå : Á¦Ç° À¯Çüº°, °Ë»ç ¹æ¹ýº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¿¹Ãø(2025-2032³â)Cholesterol Testing Products and Services Market, By Product Type, By Testing Method, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032 |
ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀåÀÇ ±Ô¸ð´Â 2024³â¿¡ 193¾ï 4,525¸¸ ´Þ·¯¿¡ À̸£·¶À¸¸ç 2025³âºÎÅÍ 2032³â¿¡ °ÉÃÄ CAGR 8.5%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.
ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀå¿¡´Â Ç÷¾×¿¡¼ ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡¸¦ ÃøÁ¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â µµ±¸, ÀåÄ¡, ŰƮ ¹× ½ÇÇè½Ç ¼ºñ½º°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ Á¦Ç°Àº ½ÉÀå Áúȯ ¹× ³úÁ¹Áß°ú °°Àº ½ÉÇ÷°ü °Ç° À§ÇèÀ» Æò°¡ÇÏ´Â µ¥ Áß¿äÇÑ ÄÝ·¹½ºÅ×·ÑÀ» ÃøÁ¤ÇÏ°í ¸ð´ÏÅ͸µÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ÈÞ´ë¿ë ÄÝ·¹½ºÅ×·Ñ ÃøÁ¤±â, °Ë»ç ½ºÆ®¸³, ½Ã¾à µîÀÇ POC °Ë»ç Àåºñ¿Í »ó¼¼ÇÑ ÁöÁú ÇÁ·ÎÆÄÀϸµÀ» Á¦°øÇÏ´Â ÀÓ»ó °Ë»ç ¼ºñ½º µîÀÌ Æ÷ÇԵ˴ϴÙ.
ÄÝ·¹½ºÅ×·Ñ °ü·Ã °Ç° ¹®Á¦¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Á¤È®ÇÏ°í ½Å¼ÓÇÑ °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ºñħ½ÀÀû °Ë»ç ŰƮ ¹× °¡Á¤¿ë °Ë»ç ŰƮÀÇ ±â¼ú Çõ½Åµµ ½ÃÀåÀ» È®´ëÇÏ¿© º¸´Ù °£ÆíÇÑ ¾×¼¼½º¿Í ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. °Ç° °ü¸® Á¦°ø¾÷ü, Áø´Ü ½ÇÇè½Ç, ȯÀÚ°¡ ÁÖ¿ä »ç¿ëÀÚ·Î ³ªÅ¸³µ½À´Ï´Ù. ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ¿äÀÎÀº ¼¼°èÀûÀÎ °ËÁø ÇÁ·Î±×·¥ Áõ°¡¿Í ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ ´ëóÀ̸ç, ÄÝ·¹½ºÅ×·Ñ °Ë»ç¸¦ ÀÏ»óÈÇϰí ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ÀÌ ½ÃÀåÀº ÁöÁúÀÌ»óÁõÀÇ Á¶±â Áø´Ü°ú °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç ȯÀÚÀÇ °á°ú °³¼±¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀå - ½ÃÀå ¿ªÇÐ
°£ÆíÇÑ °¡Á¤¿ë ÄÝ·¹½ºÅ×·Ñ °Ë»ç ŰƮ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼Ó
Æí¸®ÇÑ °¡Á¤¿ë ÄÝ·¹½ºÅ×·Ñ °Ë»ç ŰƮ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø ¿äÀÎÀÔ´Ï´Ù. ¿À´Ã³¯ÀÇ ¼ÒºñÀÚµéÀº °Ç° °ü¸®½Ã¼³À» ¹æ¹®ÇÏÁö ¾Ê°í Áý¿¡¼ ÇÒ ¼ö ÀÖ´Â ºü¸£°í »ç¿ëÇϱ⠽¬¿î °Ë»ç ¼Ö·ç¼ÇÀ» ¼±È£ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼ÀÇ ¹è°æÀº °Ç° ÀǽÄÀÇ Áõ°¡¿Í ƯÈ÷ ½ÉÇ÷°ü À§ÇèÀÌ ÀÖ´Â »ç¶÷ »çÀÌ¿¡¼ ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡¸¦ Á¤±âÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰíÀÚ ÇÏ´Â ¿ä±¸¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. °¡Á¤¿ë °Ë»ç ŰƮ´Â ÇÁ¶óÀ̹ö½Ã¸¦ º¸È£ÇÏ°í ½Ã°£À» Àý¾àÇÒ ¼ö ÀÖÀ¸¸ç °á°ú°¡ Áï½Ã ³ª¿À¹Ç·Î ´õ ¸¹Àº »ç¶÷µéÀÌ ½ÉÀå °Ç°À» Àû±ØÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù.
±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ÈÞ´ë¿ë ÀåÄ¡ÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀÌ Çâ»óµÇ¾î ÀÓ»ó °Ë»ç¿Í ºñ±³ÇÒ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ COVID-19ÀÇ ´ëÀ¯ÇàÀº ¿ø°Ý °Ë»ç¿Í ¼¿ÇÁ °Ë»ç ÀÇ·á ¼Ö·ç¼ÇÀÇ Ã¤¿ëÀ» °¡¼ÓÈÇß½À´Ï´Ù. ÀÇ·á Á¦°øÀڴ ȯÀÚÀÇ ÁøÂûÀ» ÁÙÀ̰í ÀÇ·á½Ã¼³ÀÇ ºÎ´ãÀ» ÁÙÀ̱⠶§¹®¿¡ ÀçÅà °Ë»ç¸¦ ÁöÁöÇϰí ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, °¡Á¤¿ë ÄÝ·¹½ºÅ×·Ñ °Ë»ç ŰƮÀÇ ÆíÀǼº°ú Á¢±Ù¼ºÀº º¸´Ù ±¤¹üÀ§ÇÑ »ç¿ëÀÚ ±â¹ÝÀ» À¯Ä¡ÇÔÀ¸·Î½á ½ÃÀåÀ» È®´ëÇÏ°í ±â¼ú Çõ½Å°ú ¸ÅÃâ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®
´ç»çÀÇ ¸®¼Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â)¿¡ ¾à 8.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Á¦Ç° À¯Çüº°·Î´Â ÄÝ·¹½ºÅ×·Ñ °Ë»ç Àåºñ°¡ 2024³â ÃÖ´ë ½ÃÀå Á¡À¯À²À» ³ªÅ¸³Â½À´Ï´Ù.
°Ë»ç ¹æ¹ýº°·Î´Â 2024³â¿¡ È¿¼Ò ÃøÁ¤¹ýÀÌ ÁÖ¿ä °Ë»ç ¹æ¹ýÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.
ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â 2024³â¿¡´Â º´¿ø ¹× Ŭ¸®´ÐÀÌ ÁÖ¿ä °Ë»ç ¹æ¹ýÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ¸ÅÃâÀ» ÁÖµµÇÏ¿´½À´Ï´Ù.
¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀåÀº Á¦Ç° À¯Çü, °Ë»ç ¹æ¹ý, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐȵ˴ϴÙ.
½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó ÄÝ·¹½ºÅ×·Ñ °Ë»ç ÀåÄ¡, °Ë»ç ½ºÆ®¸³ & ½Ã¾à, ¼ÒÇÁÆ®¿þ¾î ¹× ¼ºñ½º·Î ºÐ·ùµË´Ï´Ù. ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀå¿¡¼ Á¦Ç° À¯Çüº°·Î °¡Àå Áß¿äÇÑ ºÎ¹®Àº ÄÝ·¹½ºÅ×·Ñ °Ë»ç ÀåºñÀÔ´Ï´Ù. ÈÞ´ëÇü ¹× Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ¹ÌÅ͸¦ Æ÷ÇÔÇÑ ÀÌ·¯ÇÑ Àåºñ´Â ºü¸£°í Á¤È®ÇÑ ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡ ÃøÁ¤ÀÌ °¡´ÉÇϱ⠶§¹®¿¡ ³Î¸® ¼±È£µË´Ï´Ù.
ÇコÄɾî Àü¹®°¡¿Í ¼ÒºñÀÚ ¸ðµÎ ÄÝ·¹½ºÅ×·ÑÀ» °£ÆíÇÏ°Ô ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ¾î ½ÉÇ÷°ü À§ÇèÀÇ ½Ã±â ÀûÀýÇÑ Áø´Ü ¹× °ü¸®¸¦ Áö¿øÇÕ´Ï´Ù. °¡Á¤¿ë °Ë»ç ÀåºñÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀåºñÀÇ Á¤È®¼ºÀ» ³ôÀÌ´Â ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ÀÌ ºÎ¹®ÀÇ ÀÌÁ¡Àº ´õ¿í °ÇØÁö°í ÀÖ½À´Ï´Ù.
½ÃÀåÀº °Ë»ç ¹æ¹ý¿¡ µû¶ó È¿¼Ò ÃøÁ¤¹ý, ¸é¿ª ÃøÁ¤¹ý, ºñ»ö ÃøÁ¤¹ýÀÇ ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀå¿¡¼ °¡Àå ¿ì¼¼ÇÑ °Ë»ç¹ýÀº È¿¼Ò¹ýÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀº ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡¸¦ ÃøÁ¤ÇÒ ¶§ ³ôÀº Á¤È®µµ, ½Å·Ú¼º ¹× »ç¿ë ÆíÀǼºÀ¸·Î ³Î¸® Áö¿øµË´Ï´Ù. È¿¼Ò ¹æ¹ýÀº ƯÁ¤ È¿¼Ò¸¦ »ç¿ëÇÏ¿© Ç÷¾× ½Ã·áÀÇ ÄÝ·¹½ºÅ׷Ѱú ¹ÝÀÀÇÏ¿© ÄÝ·¹½ºÅ×·Ñ ³óµµ¿Í »ó°üµÇ´Â ÃøÁ¤ ½ÅÈ£¸¦ »ý¼ºÇÕ´Ï´Ù.
ÀÚµ¿ºÐ¼®±â¿ÍÀÇ È£È¯¼º°ú ºü¸¥ ó¸® ½Ã°£À¸·Î ÀÓ»ó ½ÇÇè½Ç°ú Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç ¸ðµÎ¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ÀÌ °Ë»ç¹ýÀÇ È¿À²¼º°ú Á¤¹Ðµµ´Â ½ÃÀå¿¡¼ÀÇ °ÇÑ Á¸Àç°¨°ú Àα⠻ó½Â¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.
ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®
ºÏ¹Ì´Â ÷´Ü °Ç° °ü¸® ÀÎÇÁ¶ó¿Í ½ÉÇ÷°ü °Ç°¿¡ ´ëÇÑ ³ôÀº ÀνÄÀ¸·Î ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀå¿¡¼ Áß¿äÇÑ ÁöÀ§¸¦ Â÷ÁöÇÕ´Ï´Ù. ÀÌ Áö¿ª¿¡¼´Â ÃÖ÷´Ü Áø´Ü ±â¼úÀÌ ³Î¸® äÅõǾî Á¾ÇÕÀûÀÎ ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º¸¦ Á¦°øÇÏ´Â °Ç° °ü¸® Á¦°ø¾÷üÀÇ Á¸Àç°¡ Å®´Ï´Ù. »ýȰ½À°üº´ Áõ°¡³ª ¿¹¹æÀǷḦ ÃßÁøÇÏ´Â Á¤ºÎÀÇ ´ëó°¡ ÄÝ·¹½ºÅ×·Ñ ¸ð´ÏÅ͸µ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
°Ô´Ù°¡ ºÏ¹Ì ¼ÒºñÀÚµéÀº °¡Á¤¿ë ŰƮ¸¦ Æ÷ÇÔÇÑ Æí¸®Çϰí Çõ½ÅÀûÀÎ °Ë»ç ¿É¼ÇÀ» ¼±È£ÇÏ´Â °æÇâÀÌ ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. À¯¸íÇÑ Áø´Ü °Ë»ç±â°üÀÇ Á¸Àç¿Í °Ë»ç Á¤¹Ðµµ¸¦ Çâ»ó½Ã۱â À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸°¡ ½ÃÀåÀ» ´õ¿í °ÈÇϰí ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ºÏ¹Ì´Â ¿©ÀüÈ÷ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½ºÀÇ Çõ½Å, Á¢±Ù¼º ¹× ä¿ëÀ» ÃËÁøÇÏ´Â ÁÖ¿ä Áö¿ªÀÔ´Ï´Ù.
¹Ì±¹Àº °ß°íÇÑ °Ç° °ü¸® ½Ã½ºÅÛ°ú ½ÉÇ÷°ü Áúȯ¿¡ ´ëÇÑ ³ôÀº ÀνÄÀ¸·Î ºÏ¹Ì ³» ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ³ª¶ó¿¡¼´Â °í±Þ Áø´Ü µµ±¸¸¦ ³Î¸® »ç¿ëÇÒ ¼ö ÀÖÀ¸¸ç ÀÓ»ó ¹× °¡Á¤¿¡¼ ÄÝ·¹½ºÅ×·Ñ °Ë»ç¸¦ Á¦°øÇÏ´Â °Ç° °ü¸® Á¦°ø¾÷üÀÇ ³×Æ®¿öÅ©°¡ Ãæ½ÇÇÏ´Ù´Â ÀÌÁ¡ÀÌ ÀÖ½À´Ï´Ù. ¿¹¹æ °Ç° °ü¸®¿¡ ´ëÇÑ ³ë·Â°ú Á¤±âÀûÀÎ °Ç° Áø´ÜÀ» ÅëÇØ ±¹°¡´Â Á¤±âÀûÀÎ ÄÝ·¹½ºÅ×·Ñ ÃøÁ¤À» Á¦°øÇÕ´Ï´Ù.
°Ô´Ù°¡ ±â¼ú Çõ½Å°ú Æí¸®ÇÑ ÀçÅà °Ë»ç ¿É¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ Áõ°¡°¡ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÃÀåÀº °Ë»ç Á¤¹Ðµµ¿Í »ç¿ë ÆíÀǼº Çâ»óÀ» ¸ñÇ¥·Î ÇÏ´Â R&D ³ë·Â¿¡µµ ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ¹Ì±¹Àº ¿©ÀüÈ÷ ÄÝ·¹½ºÅ×·Ñ °Ë»çÀÇ ¼ºÀå°ú Çõ½ÅÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ½ÃÀåÀÔ´Ï´Ù.
ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ¹× ¼ºñ½º ½ÃÀåÀº °æÀïÀÌ ½ÉÇÏ°í ±âÁ¸ ¼¼°è ±â¾÷°ú Çõ½ÅÀû ½ÅÈï ±â¾÷ÀÌ Á¸ÀçÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. Abbott Laboratories, Roche Diagnostics, Siemens Healthineers ¹× Johnson & Johnson°ú °°Àº ÁÖ¿ä ±â¾÷Àº ÷´Ü ÄÝ·¹½ºÅ×·Ñ °Ë»ç Àåºñ ¹× °Ë»ç ¼ºñ½ºÀÇ ±¤¹üÀ§ÇÑ Æ÷Æ®Æú¸®¿À¿¡¼ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ È¸»çµéÀº ÈÞ´ë¿ë °Ë»ç ŰƮ ¹× °¡Á¤¿ë °Ë»ç ŰƮ¸¦ Æ÷ÇÔÇÑ ÀÚ»ç Á¦Ç°ÀÇ Á¤È®¼º, ¼Óµµ ¹× »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ã۱â À§ÇØ Áö¼ÓÀûÀ¸·Î ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.
Danaher Corporation ¹× Bio-Rad Laboratories¿Í °°Àº ±â¾÷Àº ½ÃÀå¿¡¼ÀÇ Á¸Àç°¨À» ³ôÀ̱â À§ÇØ Àü·«Àû Á¦ÈÞ ¹× Àμö¸¦ ÅëÇØ Á¦Ç° ¶óÀÎ È®´ë¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ARKRAY ¹× Nova Biomedical°ú °°Àº Áö¿ª ±â¾÷Àº ºñ¿ëÈ¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ¼Ö·ç¼ÇÀ¸·Î ƯÁ¤ ½ÃÀåÀ» Áö¿øÇÕ´Ï´Ù. °æÀï ±¸µµ´Â ±â¼úÀÇ Áøº¸, ±ÔÁ¦´ç±¹ÀÇ ½ÂÀÎ, ºñħ½ÀÀûÀÌ°í ½Å¼ÓÇÑ °Ë»ç¹ý¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡¿¡ µû¶ó Çü¼ºµË´Ï´Ù. Àü¹ÝÀûÀ¸·Î Çõ½Å, Á¦Ç° ǰÁú ¹× ±¤¹üÀ§ÇÑ ÃÖÁ¾ »ç¿ëÀÚ ³×Æ®¿öÅ©´Â ÀÌ ½ÃÀå¿¡¼ °æÀï·ÂÀ» À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
Cholesterol Testing Products and Services Market size was valued at US$ 19,345.25 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.
The Cholesterol Testing Products and Services Market encompasses the tools, devices, kits, and laboratory services used to measure cholesterol levels in blood. These products help detect and monitor cholesterol, which is crucial for assessing cardiovascular health risks such as heart disease and stroke. The market includes point-of-care testing devices like portable cholesterol meters, test strips, and reagents, as well as clinical laboratory services offering detailed lipid profiling.
Rising awareness about cholesterol-related health issues and the growing prevalence of cardiovascular diseases drive demand for accurate and quick testing solutions. Innovations in non-invasive and home-based testing kits are also expanding the market, allowing easier access and frequent monitoring. Healthcare providers, diagnostic labs, and patients are the primary users. The market growth is supported by increasing screening programs and preventive healthcare initiatives worldwide, making cholesterol testing a routine health check. Overall, this market plays a vital role in the early diagnosis and management of lipid disorders, contributing to better patient outcomes.
Cholesterol Testing Products and Services Market- Market Dynamics
The growing demand for convenient home-based cholesterol testing kits boosts market growth.
The growing demand for convenient home-based cholesterol testing kits is a key driver of the Cholesterol Testing Products and Services Market. Consumers today prefer quick, easy-to-use testing solutions that can be done at home without visiting a healthcare facility. This trend is driven by increasing health awareness and the desire for regular monitoring of cholesterol levels, especially among individuals with cardiovascular risks. Home-based kits offer privacy, time-saving benefits, and immediate results, encouraging more people to proactively manage their heart health.
Advances in technology have improved the accuracy and reliability of these portable devices, making them comparable to clinical tests. Additionally, the COVID-19 pandemic accelerated the adoption of remote and self-testing healthcare solutions. Healthcare providers also support home testing as it reduces patient visits and eases the burden on medical facilities. Overall, the convenience and accessibility of home cholesterol testing kits are expanding the market by attracting a broader user base, driving innovation and sales growth.
Cholesterol Testing Products and Services Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2025-2032)
Based on product type segmentation, Cholesterol Testing Devices was predicted to show maximum market share in the year 2024
Based on Testing Method segmentation, Enzymatic Assays were the leading Testing Method in 2024
Based on End-user segmentation, Hospitals & Clinics were the leading Testing Method in 2024
Based on region, North America was the leading revenue generator in 2024
The Global Cholesterol Testing Products and Services Market is segmented on the basis of Product Type, Testing Method, End-user, and Region.
The market is divided into three categories based on product type: Cholesterol Testing Devices, Test Strips & Reagents, Software & Services. The most dominant segment by product type in the Cholesterol Testing Products and Services Market is Cholesterol Testing Devices. These devices, including portable and point-of-care meters, are widely preferred due to their ability to deliver quick and accurate cholesterol level results.
They enable both healthcare professionals and consumers to monitor cholesterol conveniently, supporting timely diagnosis and management of cardiovascular risks. The increasing adoption of home-based testing devices and advancements in technology enhancing device accuracy further strengthen this segment's dominance.
The market is divided into three categories based on Testing Method: Enzymatic Assays, Immunoassays, and Colorimetric Assays. The most dominant testing method in the Cholesterol Testing Products and Services Market is Enzymatic Assays. This method is widely favored due to its high accuracy, reliability, and ease of use in measuring cholesterol levels. Enzymatic assays use specific enzymes to react with cholesterol in blood samples, producing measurable signals that correlate with cholesterol concentration.
Their compatibility with automated analyzers and rapid processing time makes them ideal for both clinical laboratories and point-of-care testing. The method's efficiency and precision contribute significantly to its strong presence and preference in the market.
Cholesterol Testing Products and Services Market- Geographical Insights
North America holds a significant position in the Cholesterol Testing Products and Services Market due to advanced healthcare infrastructure and high awareness about cardiovascular health. The region benefits from widespread adoption of cutting-edge diagnostic technologies and a strong presence of healthcare providers offering comprehensive cholesterol testing services. The increasing prevalence of lifestyle-related diseases and government initiatives promoting preventive healthcare contribute to the growing demand for cholesterol monitoring.
Additionally, consumers in North America show a preference for convenient and innovative testing options, including home-based kits, which fuels market growth. The presence of well-established diagnostic laboratories and ongoing research to improve testing accuracy further strengthens the market. Overall, North America remains a key region driving innovation, accessibility, and adoption of Cholesterol Testing Products and Services.
The United States dominates the Cholesterol Testing Products and Services Market within North America due to its robust healthcare system and high awareness of cardiovascular diseases. The country benefits from widespread availability of advanced diagnostic tools and a strong network of healthcare providers offering both clinical and home-based cholesterol testing. Preventive healthcare initiatives and routine health screenings encourage regular cholesterol monitoring among the population.
Additionally, technological innovations and growing consumer preference for convenient, at-home testing options drive market expansion. The U.S. market is also supported by research and development efforts aimed at improving test accuracy and ease of use. Overall, the United States remains a critical market fostering growth and innovation in cholesterol testing.
The Cholesterol Testing Products and Services Market is highly competitive, characterized by the presence of several established global players and innovative startups. Key companies like Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Johnson & Johnson dominate the market with a broad portfolio of advanced cholesterol testing devices and laboratory services. These players continuously invest in research and development to enhance the accuracy, speed, and user-friendliness of their products, including portable and home-based testing kits.
Companies such as Danaher Corporation and Bio-Rad Laboratories focus on expanding their product lines through strategic partnerships and acquisitions to strengthen market presence. Additionally, regional players like ARKRAY and Nova Biomedical cater to specific markets with cost-effective and easy-to-use solutions. The competitive landscape is also shaped by advancements in technology, regulatory approvals, and growing consumer demand for non-invasive and rapid testing methods. Overall, innovation, product quality, and wide End-user networks are crucial for maintaining a competitive edge in this market.
In June 2025, Abbott Laboratories announced the launch of its latest portable cholesterol testing device, designed for enhanced accuracy and faster results, aiming to improve at-home cardiovascular health monitoring.